Skip to main content
Top
Published in: Endocrine 2/2024

25-11-2023 | Insulins | Original Article

Association between experience of insulin resistance and long-term cardiovascular disease risk: findings from the Korean Genome and Epidemiology Study (KOGES)

Authors: Jong Hee Lee, Hye Sun Lee, Soyoung Jeon, Yong-Jae Lee, Byoungjin Park, Jun-Hyuk Lee, Yu-Jin Kwon

Published in: Endocrine | Issue 2/2024

Login to get access

Abstract

Purpose

Although the correlation between insulin resistance (IR) and cardiovascular disease (CVD) risk is well-established, the impact of changes in IR status over time has received little attention. This study aimed to investigate the effect of IR on CVD risk in a large prospective cohort of middle-aged Korean adults.

Methods

We assessed 3597 participants from the Korean Genome and Epidemiology Study (KoGES). Participants were categorized as having IR if their HOMA-IR was ≥2.5 at least once during the exposure period. Multivariate Cox proportional hazards regression analysis was performed to assess hazard ratios (HRs) with 95% CIs for incident CVD after adjusting for confounders.

Results

Among a total of 3597 participants, 2259 did not have IR and 1138 had IR. The cumulative incidence rate of CVD in the IR group was significantly higher than that in the non-IR group (log-rank test, p = 0.015). Compared to the non-IR group, the HR and 95% CI for incident CVD in the IR group was 1.40 (1.07–1.83) in the unadjusted model. The presence of IR during the exposure period was significantly associated with a higher risk of incident CVD after adjusting for age, sex, body mass index, diabetes, hypertension, dyslipidemia, C-reactive protein, physical activity, alcohol intake, and smoking status (HR = 1.37; 95% CI: 1.01–1.84).

Conclusion

Individuals who have experienced IR have a consistently higher likelihood of developing CVD than those who have never had IR. More intensive efforts should be made to prevent IR in middle-aged and older adults.
Appendix
Available only for authorised users
Literature
1.
go back to reference R. Jagannathan, S.A. Patel, M.K. Ali, K.M.V. Narayan, Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr. Diab. Rep. 19(7), 44 (2019)CrossRefPubMed R. Jagannathan, S.A. Patel, M.K. Ali, K.M.V. Narayan, Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr. Diab. Rep. 19(7), 44 (2019)CrossRefPubMed
2.
go back to reference B. Dahlof, Cardiovascular disease risk factors: epidemiology and risk assessment. Am. J. Cardiol. 105(1 Suppl), 3A–9A (2010)CrossRefPubMed B. Dahlof, Cardiovascular disease risk factors: epidemiology and risk assessment. Am. J. Cardiol. 105(1 Suppl), 3A–9A (2010)CrossRefPubMed
5.
go back to reference V. Ormazabal, S. Nair, O. Elfeky, C. Aguayo, C. Salomon, F.A. Zuniga, Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol 17(1), 122 (2018)CrossRefPubMedPubMedCentral V. Ormazabal, S. Nair, O. Elfeky, C. Aguayo, C. Salomon, F.A. Zuniga, Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol 17(1), 122 (2018)CrossRefPubMedPubMedCentral
6.
go back to reference S.-F. Tsai, C.-T. Yang, W.-J. Liu, C.-L. Lee, Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. eClinicalMedicine 58, 101934 (2023).CrossRefPubMedPubMedCentral S.-F. Tsai, C.-T. Yang, W.-J. Liu, C.-L. Lee, Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. eClinicalMedicine 58, 101934 (2023).CrossRefPubMedPubMedCentral
7.
go back to reference A. Di Pino, R.A. DeFronzo, Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocrine Rev. 40(6), 1447–1467 (2019)CrossRef A. Di Pino, R.A. DeFronzo, Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocrine Rev. 40(6), 1447–1467 (2019)CrossRef
9.
go back to reference I.M. Vladu, M. Fortofoiu, D. Clenciu, M.C. Fortofoiu, R. Padureanu, L. Radu, S.T.T. Cojan, P.M. Radulescu, V. Padureanu, Insulin resistance quantified by the value of HOMA-IR and cardiovascular risk in patients with type 2 diabetes. Exp. Ther. Med. 23(1), 73 (2022)CrossRefPubMed I.M. Vladu, M. Fortofoiu, D. Clenciu, M.C. Fortofoiu, R. Padureanu, L. Radu, S.T.T. Cojan, P.M. Radulescu, V. Padureanu, Insulin resistance quantified by the value of HOMA-IR and cardiovascular risk in patients with type 2 diabetes. Exp. Ther. Med. 23(1), 73 (2022)CrossRefPubMed
10.
go back to reference M.M. Adeva-Andany, J. Martinez-Rodriguez, M. Gonzalez-Lucan, C. Fernandez-Fernandez, E. Castro-Quintela, Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab. Synd. 13(2), 1449–1455 (2019)CrossRef M.M. Adeva-Andany, J. Martinez-Rodriguez, M. Gonzalez-Lucan, C. Fernandez-Fernandez, E. Castro-Quintela, Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab. Synd. 13(2), 1449–1455 (2019)CrossRef
11.
go back to reference V. Ormazabal, S. Nair, O. Elfeky, C. Aguayo, C. Salomon, F.A. Zuñiga, Association between insulin resistance and the development of cardiovascular disease. Cardiovascular Diabetol. 17(1), 122 (2018)CrossRef V. Ormazabal, S. Nair, O. Elfeky, C. Aguayo, C. Salomon, F.A. Zuñiga, Association between insulin resistance and the development of cardiovascular disease. Cardiovascular Diabetol. 17(1), 122 (2018)CrossRef
12.
go back to reference K.B. Gast, N. Tjeerdema, T. Stijnen, J.W.A. Smit, O.M. Dekkers, Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLOS ONE 7(12), e52036 (2012)CrossRefPubMedPubMedCentral K.B. Gast, N. Tjeerdema, T. Stijnen, J.W.A. Smit, O.M. Dekkers, Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLOS ONE 7(12), e52036 (2012)CrossRefPubMedPubMedCentral
13.
go back to reference M.-C. Lu, W.-C. Fang, W.-C. Li, W.-C. Yeh, Y.-H. Shieh, J.-Y. Chen, The association between insulin resistance and cardiovascular disease risk: a community-based cross-sectional study among Taiwanese people aged over 50 years. Int. J. Environ. Res. Public Health 17(19), 7195 (2020)CrossRefPubMedPubMedCentral M.-C. Lu, W.-C. Fang, W.-C. Li, W.-C. Yeh, Y.-H. Shieh, J.-Y. Chen, The association between insulin resistance and cardiovascular disease risk: a community-based cross-sectional study among Taiwanese people aged over 50 years. Int. J. Environ. Res. Public Health 17(19), 7195 (2020)CrossRefPubMedPubMedCentral
14.
15.
go back to reference E. Bonora, G. Targher, M. Alberiche, R.C. Bonadonna, F. Saggiani, M.B. Zenere, T. Monauni, M. Muggeo, Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23(1), 57–63 (2000)CrossRefPubMed E. Bonora, G. Targher, M. Alberiche, R.C. Bonadonna, F. Saggiani, M.B. Zenere, T. Monauni, M. Muggeo, Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23(1), 57–63 (2000)CrossRefPubMed
16.
go back to reference T. Wang, M. Li, T. Zeng, R. Hu, Y. Xu, M. Xu, Z. Zhao, Y. Chen, S. Wang, H. Lin, X. Yu, G. Chen, Q. Su, Y. Mu, L. Chen, X. Tang, L. Yan, G. Qin, Q. Wan, Z. Gao, G. Wang, F. Shen, Z. Luo, Y. Qin, L. Chen, Y. Huo, Q. Li, Z. Ye, Y. Zhang, C. Liu, Y. Wang, S. Wu, T. Yang, H. Deng, J. Zhao, L. Shi, G. Ning, Y. Bi, W. Wang, J. Lu, Association between insulin resistance and cardiovascular disease risk varies according to glucose tolerance status: a nationwide prospective cohort study. Diabetes Care 45(8), 1863–1872 (2022)CrossRefPubMedPubMedCentral T. Wang, M. Li, T. Zeng, R. Hu, Y. Xu, M. Xu, Z. Zhao, Y. Chen, S. Wang, H. Lin, X. Yu, G. Chen, Q. Su, Y. Mu, L. Chen, X. Tang, L. Yan, G. Qin, Q. Wan, Z. Gao, G. Wang, F. Shen, Z. Luo, Y. Qin, L. Chen, Y. Huo, Q. Li, Z. Ye, Y. Zhang, C. Liu, Y. Wang, S. Wu, T. Yang, H. Deng, J. Zhao, L. Shi, G. Ning, Y. Bi, W. Wang, J. Lu, Association between insulin resistance and cardiovascular disease risk varies according to glucose tolerance status: a nationwide prospective cohort study. Diabetes Care 45(8), 1863–1872 (2022)CrossRefPubMedPubMedCentral
17.
go back to reference T. Wang, J. Lu, L. Shi, G. Chen, M. Xu, Y. Xu, Q. Su, Y. Mu, L. Chen, R. Hu, X. Tang, X. Yu, M. Li, Z. Zhao, Y. Chen, L. Yan, G. Qin, Q. Wan, M. Dai, D. Zhang, Z. Gao, G. Wang, F. Shen, Z. Luo, Y. Qin, L. Chen, Y. Huo, Q. Li, Z. Ye, Y. Zhang, C. Liu, Y. Wang, S. Wu, T. Yang, H. Deng, J. Zhao, S. Lai, Y. Bi, R.A. DeFronzo, W. Wang, G. Ning, Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol 8(2), 115–124 (2020)CrossRefPubMed T. Wang, J. Lu, L. Shi, G. Chen, M. Xu, Y. Xu, Q. Su, Y. Mu, L. Chen, R. Hu, X. Tang, X. Yu, M. Li, Z. Zhao, Y. Chen, L. Yan, G. Qin, Q. Wan, M. Dai, D. Zhang, Z. Gao, G. Wang, F. Shen, Z. Luo, Y. Qin, L. Chen, Y. Huo, Q. Li, Z. Ye, Y. Zhang, C. Liu, Y. Wang, S. Wu, T. Yang, H. Deng, J. Zhao, S. Lai, Y. Bi, R.A. DeFronzo, W. Wang, G. Ning, Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol 8(2), 115–124 (2020)CrossRefPubMed
18.
go back to reference M.A. Abdul-Ghani, A. Jayyousi, R.A. DeFronzo, N. Asaad, J. Al-Suwaidi, Insulin resistance the link between T2DM and CVD: basic mechanisms and clinical implications. Curr. Vasc. Pharmacol. 17(2), 153–163 (2019)CrossRefPubMed M.A. Abdul-Ghani, A. Jayyousi, R.A. DeFronzo, N. Asaad, J. Al-Suwaidi, Insulin resistance the link between T2DM and CVD: basic mechanisms and clinical implications. Curr. Vasc. Pharmacol. 17(2), 153–163 (2019)CrossRefPubMed
19.
go back to reference S.F. Tsai, C.T. Yang, W.J. Liu, C.L. Lee, Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. EClinicalMedicine 58, 101934 (2023)CrossRefPubMedPubMedCentral S.F. Tsai, C.T. Yang, W.J. Liu, C.L. Lee, Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. EClinicalMedicine 58, 101934 (2023)CrossRefPubMedPubMedCentral
20.
go back to reference Y. Kim, B.G. Han, G.E.S.G. Ko, Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium. Int. J. Epidemiol. 46(2), e20 (2017)CrossRefPubMed Y. Kim, B.G. Han, G.E.S.G. Ko, Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium. Int. J. Epidemiol. 46(2), e20 (2017)CrossRefPubMed
21.
go back to reference R. Muniyappa, S. Lee, H. Chen, M.J. Quon, Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am. J. Physiol. Endocrinol. Metab. 294(1), E15–E26 (2008)CrossRefPubMed R. Muniyappa, S. Lee, H. Chen, M.J. Quon, Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am. J. Physiol. Endocrinol. Metab. 294(1), E15–E26 (2008)CrossRefPubMed
22.
go back to reference C. Yamada, T. Mitsuhashi, N. Hiratsuka, F. Inabe, N. Araida, E. Takahashi, Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J. Diabetes Investig. 2(5), 373–376 (2011)CrossRefPubMedPubMedCentral C. Yamada, T. Mitsuhashi, N. Hiratsuka, F. Inabe, N. Araida, E. Takahashi, Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J. Diabetes Investig. 2(5), 373–376 (2011)CrossRefPubMedPubMedCentral
23.
go back to reference D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)CrossRefPubMed D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412–419 (1985)CrossRefPubMed
24.
go back to reference K.J. Yun, K. Han, M.K. Kim, Y.M. Park, K.H. Baek, K.H. Song, H.S. Kwon, Insulin resistance distribution and cut-off value in Koreans from the 2008–2010 Korean National Health and Nutrition Examination Survey. PLoS One 11(4), e0154593 (2016)CrossRefPubMedPubMedCentral K.J. Yun, K. Han, M.K. Kim, Y.M. Park, K.H. Baek, K.H. Song, H.S. Kwon, Insulin resistance distribution and cut-off value in Koreans from the 2008–2010 Korean National Health and Nutrition Examination Survey. PLoS One 11(4), e0154593 (2016)CrossRefPubMedPubMedCentral
25.
go back to reference S.H. Park, W.Y. Lee, E.J. Rhee, W.K. Jeon, B.I. Kim, S.H. Ryu, S.W. Kim, Relative risks of the metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults. Clin. Sci. (Lond) 108(6), 553–559 (2005)CrossRefPubMed S.H. Park, W.Y. Lee, E.J. Rhee, W.K. Jeon, B.I. Kim, S.H. Ryu, S.W. Kim, Relative risks of the metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults. Clin. Sci. (Lond) 108(6), 553–559 (2005)CrossRefPubMed
26.
go back to reference H. Han, Y. Wang, T. Li, C. Feng, C. Kaliszewski, Y. Su, Y. Wu, J. Zhou, L. Wang, G. Zong, Sleep duration and risks of incident cardiovascular disease and mortality among people with type 2 diabetes. Diabetes Care 46(1), 101–110 (2023)CrossRefPubMed H. Han, Y. Wang, T. Li, C. Feng, C. Kaliszewski, Y. Su, Y. Wu, J. Zhou, L. Wang, G. Zong, Sleep duration and risks of incident cardiovascular disease and mortality among people with type 2 diabetes. Diabetes Care 46(1), 101–110 (2023)CrossRefPubMed
27.
go back to reference P.C. Dempsey, A.V. Rowlands, T. Strain, F. Zaccardi, N. Dawkins, C. Razieh, M.J. Davies, K.K. Khunti, C.L. Edwardson, K. Wijndaele, S. Brage, T. Yates, Physical activity volume, intensity, and incident cardiovascular disease. Eur. Heart J. 43(46), 4789–4800 (2022)CrossRefPubMed P.C. Dempsey, A.V. Rowlands, T. Strain, F. Zaccardi, N. Dawkins, C. Razieh, M.J. Davies, K.K. Khunti, C.L. Edwardson, K. Wijndaele, S. Brage, T. Yates, Physical activity volume, intensity, and incident cardiovascular disease. Eur. Heart J. 43(46), 4789–4800 (2022)CrossRefPubMed
28.
go back to reference A.J. Hanley, K. Williams, M.P. Stern, S.M. Haffner, Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25(7), 1177–1184 (2002)CrossRefPubMed A.J. Hanley, K. Williams, M.P. Stern, S.M. Haffner, Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25(7), 1177–1184 (2002)CrossRefPubMed
29.
go back to reference E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, V. Cacciatori, L. Santi, G. Targher, R. Bonadonna, M. Muggeo, HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25(7), 1135–1141 (2002)CrossRefPubMed E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, V. Cacciatori, L. Santi, G. Targher, R. Bonadonna, M. Muggeo, HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25(7), 1135–1141 (2002)CrossRefPubMed
31.
go back to reference H. Ikezaki, E. Lim, L.A. Cupples, C.T. Liu, B.F. Asztalos, E.J. Schaefer, Small dense low-density lipoprotein cholesterol is the most atherogenic lipoprotein parameter in the prospective framingham offspring study. J. Am. Heart Assoc. 10(5), e019140 (2021)CrossRefPubMedPubMedCentral H. Ikezaki, E. Lim, L.A. Cupples, C.T. Liu, B.F. Asztalos, E.J. Schaefer, Small dense low-density lipoprotein cholesterol is the most atherogenic lipoprotein parameter in the prospective framingham offspring study. J. Am. Heart Assoc. 10(5), e019140 (2021)CrossRefPubMedPubMedCentral
32.
go back to reference M.S. Zhou, I.H. Schulman, L. Raij, Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. J Hypertens 28(3), 527–535 (2010)CrossRefPubMed M.S. Zhou, I.H. Schulman, L. Raij, Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation. J Hypertens 28(3), 527–535 (2010)CrossRefPubMed
33.
go back to reference H. Li, Y. Meng, S. He, X. Tan, Y. Zhang, X. Zhang, L. Wang, W. Zheng, Macrophages, chronic inflammation, and insulin resistance. Cells 11(19), 3001 (2022). CrossRefPubMedPubMedCentral H. Li, Y. Meng, S. He, X. Tan, Y. Zhang, X. Zhang, L. Wang, W. Zheng, Macrophages, chronic inflammation, and insulin resistance. Cells 11(19), 3001 (2022). CrossRefPubMedPubMedCentral
34.
go back to reference A. Avogaro, M. Albiero, L. Menegazzo, S. de Kreutzenberg, G.P. Fadini, Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 34(Suppl 2), S285–S290 (2011)CrossRefPubMedPubMedCentral A. Avogaro, M. Albiero, L. Menegazzo, S. de Kreutzenberg, G.P. Fadini, Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 34(Suppl 2), S285–S290 (2011)CrossRefPubMedPubMedCentral
35.
go back to reference D. Eddy, L. Schlessinger, R. Kahn, B. Peskin, R. Schiebinger, Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care 32(2), 361–366 (2009)CrossRefPubMedPubMedCentral D. Eddy, L. Schlessinger, R. Kahn, B. Peskin, R. Schiebinger, Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care 32(2), 361–366 (2009)CrossRefPubMedPubMedCentral
36.
go back to reference I. Baik, N.H. Cho, S.H. Kim, C. Shin, Dietary information improves cardiovascular disease risk prediction models. Eur. J. Clin. Nutr. 67(1), 25–30 (2013)CrossRefPubMed I. Baik, N.H. Cho, S.H. Kim, C. Shin, Dietary information improves cardiovascular disease risk prediction models. Eur. J. Clin. Nutr. 67(1), 25–30 (2013)CrossRefPubMed
37.
go back to reference J.H. Baek, H. Kim, K.Y. Kim, J. Jung, Insulin resistance and the risk of diabetes and dysglycemia in Korean general adult population. Diabetes Metab. J. 42(4), 296–307 (2018)CrossRefPubMedPubMedCentral J.H. Baek, H. Kim, K.Y. Kim, J. Jung, Insulin resistance and the risk of diabetes and dysglycemia in Korean general adult population. Diabetes Metab. J. 42(4), 296–307 (2018)CrossRefPubMedPubMedCentral
38.
go back to reference A. Abdesselam, H. Zidoum, F. Zadjali, R. Hedjam, A. Al-Ansari, R. Bayoumi, S. Al-Yahyaee, M. Hassan, S. Albarwani, Estimate of the HOMA-IR cut-off value for identifying subjects at risk of insulin resistance using a machine learning approach. Sultan Qaboos Univ. Med. J. 21(4), 604–612 (2021)CrossRefPubMedPubMedCentral A. Abdesselam, H. Zidoum, F. Zadjali, R. Hedjam, A. Al-Ansari, R. Bayoumi, S. Al-Yahyaee, M. Hassan, S. Albarwani, Estimate of the HOMA-IR cut-off value for identifying subjects at risk of insulin resistance using a machine learning approach. Sultan Qaboos Univ. Med. J. 21(4), 604–612 (2021)CrossRefPubMedPubMedCentral
39.
go back to reference B. Kim, H.Y. Choi, W. Kim, C. Ahn, J. Lee, J.G. Kim, J. Kim, H. Shin, J.M. Yu, S. Moon, The cut-off values of surrogate measures for insulin resistance in the Korean population according to the Korean Genome and Epidemiology Study (KOGES). PLoS One 13(11), e0206994 (2018)CrossRefPubMedPubMedCentral B. Kim, H.Y. Choi, W. Kim, C. Ahn, J. Lee, J.G. Kim, J. Kim, H. Shin, J.M. Yu, S. Moon, The cut-off values of surrogate measures for insulin resistance in the Korean population according to the Korean Genome and Epidemiology Study (KOGES). PLoS One 13(11), e0206994 (2018)CrossRefPubMedPubMedCentral
Metadata
Title
Association between experience of insulin resistance and long-term cardiovascular disease risk: findings from the Korean Genome and Epidemiology Study (KOGES)
Authors
Jong Hee Lee
Hye Sun Lee
Soyoung Jeon
Yong-Jae Lee
Byoungjin Park
Jun-Hyuk Lee
Yu-Jin Kwon
Publication date
25-11-2023
Publisher
Springer US
Keywords
Insulins
Insulins
Published in
Endocrine / Issue 2/2024
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03615-0

Other articles of this Issue 2/2024

Endocrine 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine